Drug Shortage Report for ACTONEL DR
Report ID | 95288 |
Drug Identification Number | 02370417 |
Brand name | ACTONEL DR |
Common or Proper name | risedronate |
Company Name | ALLERGAN INC |
Market Status | MARKETED |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 35MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-10-07 |
Actual start date | 2019-10-04 |
Estimated end date | 2019-10-21 |
Actual end date | 2019-10-03 |
Shortage status | Avoided shortage |
Updated date | 2019-10-03 |
Company comments | |
Health Canada comments | |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-10-03 | French | Compare |
v3 | 2019-10-03 | English | Compare |
v2 | 2019-10-03 | French | Compare |
v1 | 2019-10-03 | English | Compare |